Wierzbicki AS - Search Results

1

U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.

Scarisbrick JJ, Morris S, Azurdia R, Illidge T, Parry E, Graham-Brown R, Cowan R, Gallop-Evans E, Wachsmuth R, Eagle M, Wierzbicki AS, Soran H, Whittaker S, Wain EM. Scarisbrick JJ, et al. Among authors: wierzbicki as. Br J Dermatol. 2013 Jan;168(1):192-200. doi: 10.1111/bjd.12042. Epub 2012 Dec 3. Br J Dermatol. 2013. PMID: 22963233

2

Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression.

Khavandi K, Brownrigg J, Hankir M, Sood H, Younis N, Worth J, Greenstein A, Soran H, Wierzbicki A, Goldsmith DJ. Khavandi K, et al. Curr Vasc Pharmacol. 2014 Jan;12(1):155-67. doi: 10.2174/15701611113119990118. Curr Vasc Pharmacol. 2014. PMID: 22272898 Review.

3

The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.

Neelamekam S, Kwok S, Malone R, Wierzbicki AS, Soran H. Neelamekam S, et al. Among authors: wierzbicki as. Orphanet J Rare Dis. 2017 Sep 19;12(1):156. doi: 10.1186/s13023-017-0706-1. Orphanet J Rare Dis. 2017. PMID: 28927429 Free PMC article.

4

Combination fibrate-statin therapy for the treatment of severe hypertriglyceridaemia in renal disease.

Badawy O, Wierzbicki AS, Hilton R. Badawy O, et al. Among authors: wierzbicki as. Int J Clin Pract. 2003 Apr;57(3):249-51. Int J Clin Pract. 2003. PMID: 12723736

5

Hypertriglyceridaemia and NK cell lymphoma.

Suryanarayanan S, Wierzbicki AS, Carr R, Ritter JM. Suryanarayanan S, et al. Among authors: wierzbicki as. Int J Clin Pract. 2003 Dec;57(10):921-2. Int J Clin Pract. 2003. PMID: 14712900

6

High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.

Wierzbicki AS, Lumb PJ, Semra YK, Crook MA. Wierzbicki AS, et al. QJM. 1998 Apr;91(4):291-4. doi: 10.1093/qjmed/91.4.291. QJM. 1998. PMID: 9666952 Clinical Trial.

7

Dyslipidaemia related to insulin resistance and cardiovascular disease in South Asian and West African populations.

Ewang-Emukowhate M, Perera D, Wierzbicki AS. Ewang-Emukowhate M, et al. Among authors: wierzbicki as. Curr Pharm Des. 2014;20(40):6270-5. doi: 10.2174/1381612820666140620114948. Curr Pharm Des. 2014. PMID: 24953401 Review.

8

Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia.

Wierzbicki AS, Lumb PJ, Chik G. Wierzbicki AS, et al. Int J Clin Pract. 2001 Dec;55(10):673-5. Int J Clin Pract. 2001. PMID: 11777291 Clinical Trial.

9

Hypertriglyceridaemia and malignancy.

Wijeratne S, Wray R, Collinson PO, Wierzbicki AS. Wijeratne S, et al. Among authors: wierzbicki as. Int J Clin Pract. 2005 Feb;59(2):253-5. doi: 10.1111/j.1742-1241.2005.00419.x. Int J Clin Pract. 2005. PMID: 15854204

10

Erectile dysfunction and statin treatment in high cardiovascular risk patients.

Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ, Wierzbicki AS, Jackson G. Solomon H, et al. Among authors: wierzbicki as. Int J Clin Pract. 2006 Feb;60(2):141-5. doi: 10.1111/j.1742-1241.2006.00793.x. Int J Clin Pract. 2006. PMID: 16451283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page